Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer
German company faced 65,000 claims from people who said they developed cancer after using weedkillerA Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging that its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed on the German company...
German company faced 65,000 claims from people who said they developed cancer after using weedkiller
A Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging that its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed on the German company for close to a decade.
Judge Timothy Boyer of a state court in St Louis found the settlement “fair, reasonable and adequate”.
"Proponents and sector analysts emphasize that this development strengthens institutional transparency, addresses long-standing public priorities, and establishes a foundation for durable systemic progress."
The Guardian(Primary Reporting & Verified Documentation, The Guardian)
2026-11-20
"According to documented reports from The Guardian: German company faced 65,000 claims from people who said they developed cancer after using weedkillerA Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging that its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed o.... Documented context, event timelines, and core factual evidence remain on public record."
What is your view on “Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer”?
📊
Poll Not Available
No voluntary reader opinion poll is currently linked to this specific article.
Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].
Comment
0Upholding journalistic discourse. No registration required.
No comments yet. Share your perspective!